Need help?

Businesses for Sale and Investment

Showing 1 - 14 of 20,152 Businesses for Sale and Investment. Buy or Invest in a Business. Listed by Direct Business Owners & Business Brokers.
Filters
 

Biotechnology Business for Sale in Alcobaça, Portugal

Highly profitable and certified food innovation business group with multiple brands, spin-offs and government grants.
Privately owned food technology company, certified by the Portuguese innovation agency (SIFIDE). - Highly profitable, low fixed costs, perfect for investment. - The leading company of the group owns several brands and multiple spin-offs and is a European leader in plant-based, fermentation and sports nutrition development, with abundant press coverage. The company offers private label opportunities to clients. - No debt or loans, very well managed over the last 5 years, with more than 200% growth and permanent profit. - The leading company provides R&D services to companies and public entities and is very well connected in the R&D grants and funding business, with more than €2M submitted in grants for the next two years. - More than 15 revenue streams between R&D services, third-party manufacturing clients, public grants and innovation tenders. - Planning on verticalizing the business with the construction of a supplements laboratory and a drinks manufacturing operation in 2024, which will be financed by the state in more than 50%. - The company pays practically zero tax on profits as it is a research activity. - Its dynamics and flexibility allow to creation of products and companies in any food or supplement area. - There are 6 permanent employees and 1 part-time designer.
7.8   Alcobaça
Run Rate Sales
USD 740 thousand
EBITDA Margin
25 %
Business for Sale
USD 2.65 Mn
Contact Business

Alternative Medicine Company for Sale in Lisbon, Portugal

For Sale: Portugal based company involved in cultivating medical cannabis.
Business is involved in the agricultural industry. - We produce medical cannabis. - Business produces this cannabis on their own land. - We own a licence for production. - Business was awarded as the most potent autoflower in the world for 28% THC. - We are the highest CBD and THC, cultivators. - Business has a specific variety with up to 20% CBD with CoA. - Company is ready to start operating but due to a lack of funds for marketing and operation, the owner wants to sell the business. - Business has ample potential and opportunity to make profit. - The selling price includes the stocks that we have. - Business is open to get investors as well. - We have attached our pitch deck which we want to present to our buyers/investors.
For Sale: Portugal based company involved in cultivating medical cannabis.
7.7   Lisbon
Run Rate Sales
Nil
EBITDA Margin
Nil
Business for Sale
USD 11.7 Mn
Contact Business

Newly Established Alternative Medicine Company Seeking Loan in Aveiro, Portugal

Pre-revenue cannabis farm seeks loan to build infrastructure for GACP/GMP-compliant premium cannabis production.
Based in Aveiro, the company will specialise in GACP and GMP-compliant medicinal cannabis, catering to Europe's growing demand in the alternative medicine sector. - Having conducted R&D for over 4 years, the company is strategically positioned with INFARMED-approved licenses for import, export, and production of medicinal cannabis. - Situated on 2.4 hectares of land ready for infrastructure development, aiming to secure EUR 2 million to expedite project completion. - The company already has well-established client relationships and strategic partnerships, ensuring a fully integrated supply chain from cultivation to the sale of dried cannabis flowers to pharmaceutical clients. - The business holds no current loan obligations, relying instead on partner contributions for initial costs, highlighting a financially prudent approach. - Market trends indicate a rising global demand for medicinal cannabis, aligning with the company's operations and future growth potential. - Full operational readiness is projected within 12 months following the investment, promising swift returns for prospective investors. - Has an experienced internal and external team poised to commence operations upon receiving the necessary funding.
6.3   Aveiro
Run Rate Sales
Nil
EBITDA Margin
Nil
Business Loan
USD 2.33 Mn at 10%
Contact Business
List your business on SMERGERS.
Get visibility from 110,000+ member network of Businesses, Investors, Acquirers, Lenders and Advisors from 900+ Industries and 170+ Countries
Create Business Profile

Newly Established Alternative Medicine Company Seeking Loan in Aveiro, Portugal

Pre-revenue cannabis farm seeks loan to build infrastructure for GACP/GMP-compliant premium cannabis production.
Based in Aveiro, the company will specialise in GACP and GMP-compliant medicinal cannabis, catering to Europe's growing demand in the alternative medicine sector. - Having conducted R&D for over 4 years, the company is strategically positioned with INFARMED-approved licenses for import, export, and production of medicinal cannabis. - Situated on 2.4 hectares of land ready for infrastructure development, aiming to secure EUR 2 million to expedite project completion. - The company already has well-established client relationships and strategic partnerships, ensuring a fully integrated supply chain from cultivation to the sale of dried cannabis flowers to pharmaceutical clients. - The business holds no current loan obligations, relying instead on partner contributions for initial costs, highlighting a financially prudent approach. - Market trends indicate a rising global demand for medicinal cannabis, aligning with the company's operations and future growth potential. - Full operational readiness is projected within 12 months following the investment, promising swift returns for prospective investors. - Has an experienced internal and external team poised to commence operations upon receiving the necessary funding.
6.3   Aveiro
Run Rate Sales
Nil
EBITDA Margin
Nil
Business Loan
USD 2.33 Mn at 10%
Contact Business

Alternative Medicine Company Seeking Loan in Coimbra, Portugal

European medical cannabis producer and distributor with a license for production, sales, and export.
European company that grows and sells medical cannabis in Europe and to other countries. - We grow medical cannabis in-house in a controlled environment and distribute them to clients. - Growing 74 varieties of medical cannabis in all ranges of THC and CBD. Good opportunity for CBD products, since Europe considers it as a controlled substance. - We used to grow strawberries before and our products were considered the best strawberries in the world that used to sell at EUR 17 per kg. - We stopped growing strawberries and shifted to medical cannabis due to a family member's health reasons. - Business owner and management members have a strong knowledge of agriculture, medicine, Olímpic Sport level medicine, and pharmaceuticals. - Have a stronger demand than before due to Covid-19. - Have 2 running contracts with medical companies and expect 5-6 new contracts in 1-2 months. - Each contract is valid for 2-3 years and could be renewed. - We currently grow 200-300 kgs of medical cannabis and planning to increase the production due to more demand. - Majority of the clients are from Germany and the Netherlands. - Also working with 20 distributors who are allowed to buy and sell medical cannabis. - Have the best equipment and machinery required for the job and the facility including a cloning room, drying room, security facility, and water tanks.
European medical cannabis producer and distributor with a license for production, sales, and export.
7.2   Coimbra
Run Rate Sales
USD 2.94 million
EBITDA Margin
22 %
Business Loan
USD 2.33 Mn at 8%
Contact Business

Bio Therapeutic Drugs Company for Sale in Nea Anchialos, Greece

License for cultivation and distribution of Medical cannabis including plot and grant (840,000euros) for sale.
1. Greece's advantageous climate and geographic location make it an ideal setting for the development of a cannabis industry, leveraging abundant sunlight and easy access to European markets. 2. The company has received a substantial grant of EUR 840,000 from the development law, providing a financial boost with no repayment expectations. 3. Possessing a medical cannabis license enabling the production of up to 45 different products, the business has the potential to be among the top 10 distributors in Greece, positioning itself for significant market share. 4. The company holds licenses for cultivating and processing medicinal cannabis plants, focusing on the cultivation and processing of medicinal cannabis on a plot area of approximately 9,000 m2 in Nea Anchialos. 5. With the intention to achieve one of the highest levels of medical cannabis production in Europe over the next five years, the business has the potential to generate a gross profit of over 5 million euros. 6. The company has obtained the necessary legal documentation and licenses, including the first Installation approval license, to expedite the construction of a successful pharmaceutical cannabis facility, positioning it ahead of many others in the industry. 7. As a pioneer in Greece's medical cannabis sector, the business has the opportunity to capitalize on the location and the needs.
7.2   Nea Anchialos
Run Rate Sales
Nil
EBITDA Margin
Nil
Business for Sale
USD 210 K
Contact Business

Bio Therapeutic Drugs Company Investment Opportunity in Milan, Italy

Biotech firm focused on cancer immuno personalized therapy and exosomes for medical and cosmetic applications.
A biotech firm based in Milan, focusing on cancer immuno personalized therapy. - Has a portfolio of R&D projects and two Finished Dosage Forms (FDF) in the Italian market, including Aripiprazole and Emtricitabine + Tenofovir. - The company specializes in the development of microfluidic technology for the production and purification of Exosomes, with applications in anti-inflammatory, skin regenerative, anti-acne and atopic dermatitis, scalp rejuvenation, and hair growth treatments. - Exosomes, a key product of the company, are body-identical ingredients known for their high stability and low likelihood of causing adverse reactions. Their cell-penetrating mechanism enables them to deliver regeneration signals, making them suitable for diverse medical and cosmetic applications. - Has 3 major clients and supplied on a quarterly basis to pharmaceutical companies in Italy, Poland, and Brazil. - Operates with a network of 12 agents in addition to its 3 permanent employees. - Collaborates with Contract Manufacturing Organizations (CMOs) for the production of its pharmaceutical products. The company holds essential regulatory licenses from GMP, FDA, and the Ministry of Health, ensuring compliance with international quality and safety standards.
7.1   Milan
Run Rate Sales
USD 350 thousand
EBITDA Margin
35 %
Partial Stake Sale
USD 1.75 Mn for 25%
Contact Business

Bio Diagnostics Company Investment Opportunity in Reading, UK

Biotech company seeking funds to begin the production of AI-powered remote health monitoring devices.
Deep biotech company incubated by a leading university. - We have developed a portable device with AI-powered image recognition capabilities that can analyze Full Blood Count tests. The device will help with monitoring a patient's health from home for conditions such as leukemia and other types of cancer. - Patient can run the tests from their home and once the sample is analyzed, the results are deployed to our platform (app and browser), which is only shared with the designated doctor. - We also provide sophistical tools that help the patient and doctors to track and monitor health over time. - Have our own production facility with a capacity for 100 devices per month and the development of the device is already complete. We have also applied for a patent in the UK. - Revenue model: We will charge a monthly subscription of GBP 1,000 for medical professionals and doctors, and GBP 100 for patients. - Cost of production of each unit is around GBP 1,200 and we have already targeted the production of 1,000 pieces for the launch. - Well-experienced team of experts and medical consultants with over 30 years of industry experience.
Biotech company seeking funds to begin the production of AI-powered remote health monitoring devices.
7.4   Reading
Run Rate Sales
Nil
EBITDA Margin
Nil
Partial Stake Sale
USD 1.35 Mn for 10%
Contact Business

Biotechnology Company Investment Opportunity in Brussels, Belgium

AI-enhanced physics-based drug discovery company with diverse clientele, seeking investment for R&D activities in pipeline.
An AI-enhanced physics-based drug discovery company. - Integrates artificial intelligence, computational chemistry, and peptide science to expedite therapeutic compound discovery and optimize leads. - Discovers and optimizes active, specific, non-toxic, and patentable small molecules delivering superior drug candidates. - The company boasts a diverse clientele, with more than 6 clients including reputable organizations such as Deloitte Belgium, B. Braun, Fresenius Kabi, and UCB Pharma. - The company currently generates revenue through the provision of management consulting services for pharmaceutical and biotech companies. It operates on a per-service-based charging model. - Company is currently engaged in the development of brain-specific and selective butyrylcholinesterase inhibitors for the treatment of severe Alzheimer's. - The business is not yet profitable as it is reinvesting its revenue into research and development activities, - The company has 2 additional contract employees for R&D activities.
6.6   Brussels
Run Rate Sales
USD 140 thousand
EBITDA Margin
Nil
Partial Stake Sale
USD 580 K for 25%
Contact Business

Bio Diagnostics Company Investment Opportunity in Uxbridge, UK

Invest in pre-revenue company specializing in gene therapy, CAR-T analysis, safety testing, and risk assessment.
• Healthcare business located in the United Kingdom offering gene therapy products and services. • University spin-out with patented technology and other scientific developments in the pipeline. • Aiming to improve the safety and efficiency of gene therapy. • Top selling products will be tests to ascertain if a person can repair their DNA, testing if a virus used to deliver a gene therapy will actually be safe. • Gene therapy and CAR-T therapy is a rapidly growing field, offering great potential for the company. • Experienced team of scientists and engineers ready to create a successful business. The business is not operational currently. • Unique products and services that can be marketed to potential customers worldwide.
9   Uxbridge
Run Rate Sales
Nil
EBITDA Margin
Nil
Partial Stake Sale
USD 650 K for 25%
Contact Business

Bio Diagnostic Franchise Opportunity

Enbiosis Biotechnology, 13 Franchisees, Est'd in 2021, London HQ
  • 10+ introductions
  • 4000+ Page Views
  • 2000+ Investor Views
Company and product: Enbiosis has developed an advanced artificial intelligence algorithm that analyzes the human gut microbiome and recommends personalized food and supplements to individuals to improve their gut health and address chronic disorders such as gastrointestinal disorders, skin-related disorders, and weight loss issues. - How it works: Patients/customers send their stool samples to any NGS laboratory in their region. Enbiosis takes the raw bacterial DNA data to the local server (to avoid data protection risks) and creates a personalized report, which is sent to patients and, if required, their practitioners within minutes. - Business model: Enbiosis's microbiome test can be sold through practitioners and/or directly to customers, depending on market dynamics. Practitioners can prescribe the test to patients to generate a personalized diet plan, or patients can follow their personalized nutrition guide through the app to improve general well-being and solve their problems. - Main differentiation: Enbiosis is the only clinically proven precision diet technology that claims to address the main cause of chronic disorders. It has conducted three clinical trials and published the results in peer-reviewed journals. Enbiosis's claims are backed by scientific evidence. - The main reason why investors should consider Enbiosis: In recent years, the number of people seeking to address their health problems through alternative methods instead of pharmaceuticals has been increasing. The challenge in alternative medicine is the lack of scientific data. Enbiosis serves as a bridge between alternative medicine and conventional medicine, and there is significant market potential for Enbiosis. For example, Enbiosis has proven the effectiveness of its technology in patients with IBS, who make up about 10% of the population. Offering individuals the opportunity to solve their chronic problems simply by changing their diet within a specific period is something they are interested in and willing to try. - Additionally, investors/distributors can offer a routine follow-up program to check gut health and prevent any kind of diseases, opening the door to long-term recurring revenue. - We have a trade registration certificate to operate.
Enbiosis Biotechnology, 13 Franchisees, Est'd in 2021, London HQ
7.6   Expanding in Czechia
Exp Monthly Sales
USD 200 thousand
Space Required
0 - 80 Sq Ft
Investment Required
USD 67 K
Contact Company

Alternative Medicine Company for Sale in Skopje, North Macedonia

Business that has a valid license to grow marijuana for medical purposes is for sale.
Our company is into growing marijuana for medical purposes. - We have an equipped and well-built indoor and outdoor facility that is for the production of dry or wet cannabis flowers. - Currently, we have just done the cultivation for one season which is a process of 6 to 8 months and have a final product stored inside our facility. - The final product is approximately 350 kg, we have not yet sold the products and hence have not reported any revenue. - We have tied-up with a company in Amsterdam that provides us with the seed. - Potential revenue can be generated by selling the final product flower to medical companies, we are not yet tied up with any medical companies. - The business owner is from Albania but due to registration, legal and benefit purposes the business is registered and operating in North Macedonia. - Business does not have any loans and is run by 5 owners. The shareholding pattern is 24:20:20:20.5:15.5. - We have received a valid license from EU regulations for the cultivation and growing of marijuana for medical purposes.
Business that has a valid license to grow marijuana for medical purposes is for sale.
6.5   Skopje
Run Rate Sales
Nil
EBITDA Margin
Nil
Business for Sale
USD 3 Mn
Contact Business

Profitable Commercial Nurseries Company for Sale in Markopoulo Mesogaias, Greece

Fully equipped glass greenhouse for sale in Almyros, Greece, with a medicinal cannabis cultivation license.
The business is a fully equipped glass greenhouse located in Markopoulo Mesogaias, Greece, with a medicinal cannabis cultivation license. - Business previously operated in the commercial nursery industry, with a focus on selling vegetables, particularly lettuce, and house plants. - The greenhouse previously generated annual revenues ranging from €300,000 to €500,000 from the sale of lettuce and house plants. - Currently, the business has 45 employees, and the production plant is currently closed. However, with a little investment, the plant can be re-started. - Business received a medicinal cannabis cultivation license, and the investors initially planned to shift the business to the production of medical cannabis. However, this plan was halted for unspecified reasons. - The business possesses a valuable medicinal cannabis cultivation license, which can be transferred to the new owner for the cultivation of medical cannabis. - The business offers a unique opportunity for investors or entrepreneurs looking to enter the medicinal cannabis market in Greece.
7.6   Markopoulo Mesogaias
Run Rate Sales
Nil
EBITDA Margin
25 %
Business for Sale
USD 1.63 Mn
Contact Business

Alternative Medicine Company for Sale in Bilcza, Poland

For Sale: Non-operational business producers of CBD and other cannabinoids for use in multiple industries.
Business is dormant at the moment. - Plant extraction facility specializing in the use of solvents, with a focus on hemp. - The primary products are cannabinoid isolates and distillates. - Facility can process up to 600kg of biomass per day with two shifts of 8 hours each, staffed by 12 extraction workers and 2 laboratory personnel. - The equipment includes 3 Gilson CPC 1,000 pro units, which enable the separation and conversion of cannabinoids. Active permits and certifications: 1) Production and processing of controlled substances (THC) authorized by the Chief Pharmaceutical Inspector. 2) ISO 22000 certification - food production safety and management. 3) Sanitary and epidemiological approvals for food and cosmetic production. 4) The newly constructed building has been granted an occupancy permit for the purpose of plant extraction using solvents. 5) Extensive documentation for the entire facility, production processes, quality control, and production safety, including HACCP and ISO compliance. - Highly qualified management team comprising pharmacists, chemists, and university-educated staff. - In-house laboratory equipped with two HPLC machines used for quality control throughout each production stage. The potential for further expansion and obtaining PCA accreditation. Advanced access and security control system, CCTV, designated access areas with fingerprint readers, security guard booth, dedicated data storage server, oxygen level sensors, and fire safety procedures.
For Sale: Non-operational business producers of CBD and other cannabinoids for use in multiple industries.
7.4   Bilcza
Run Rate Sales
Nil
EBITDA Margin
Nil
Business for Sale
USD 2.83 Mn
Contact Business

Specialty Pharmaceuticals Company for Sale in Zaragoza, Spain

For Sale: Nutraceutical product patent and license for fibromyalgia and chronic fatigue syndrome treatment.
Medicine and food supplement R&D company based in Spain. - We have developed a product for fibromyalgia and chronic fatigue syndrome. - The product has been developed under a GMP quality standard. - Our product is protected under international patent and potential partners can buy / get patent rights for selected country / ies. - We have European approval to sell the product across Europe. - Fibromyalgia affects 16.5 million patients in Europe, 20 million in the USA and 32 million in India. Buyer can manufacture products and distribute to these countries for maximum sales. - Our product does not have commercial restrictions as it is a food supplement. - We’ve done a product test in Spain with the recommendation of rheumatologist of 2 General Hospitals in Spain with excellent results. - Buyer would only receive the intellectual property and sales right. The R&D lab will not be included in the transaction.
6.8   Zaragoza
Run Rate Sales
Nil
EBITDA Margin
Nil
Business for Sale
USD 3.5 Mn
Contact Business

Investing in Businesses: A Comprehensive Guide

Investing in businesses is a strategic endeavor that can significantly grow your wealth if approached knowledgeably. Whether you're a seasoned investor or just starting, understanding the intricacies of businesses for investment is crucial.

Understanding Business Investment

Business investment refers to the allocation of capital to a company with the expectation of receiving financial returns. This can occur through direct investment in a private company or by purchasing stocks and shares of publicly traded businesses.

Types of Business Investments

  1. Equity Investment: This involves purchasing shares of a company. Equity investors become partial owners and have potential returns through dividends and appreciation of the stock value.

  2. Debt Investment: Investors lend money to businesses in exchange for interest income. This can include corporate bonds or business loans.

  3. Venture Capital and Angel Investing: These are types of equity investment where investors provide capital to startups and small businesses that have potential for growth.

  4. Crowdfunding: An innovative way to invest in businesses where multiple investors contribute small amounts of capital via platforms like Kickstarter or Indiegogo.

Advantages of Investing in Businesses

  • Potential for High Returns: Businesses have the potential to grow substantially, resulting in significant returns on investment.
  • Portfolio Diversification: Investing in various businesses can diversify an investment portfolio, reducing overall risk.
  • Active Involvement: Investors can actively participate in their investments, offering guidance and support to businesses.

Risks Involved in Business Investment

Even though investing in businesses offers attractive returns, it involves certain risks:

  • Market Volatility: Economic changes can affect business profitability and stock prices.
  • Failure Risk: Especially with startups, there's always a risk of failure resulting in loss of investment.
  • Regulatory Issues: Changes in laws and regulations can impact businesses adversely.

How to Choose the Right Business for Investment

  • Research and Analysis: Understand the business model, industry sector, and financial health of the business.
  • Growth Potential: Evaluate the business's potential for growth and scalability.
  • Management Quality: A competent management team can greatly influence a business’s success.
  • Market Trends: Stay updated with market trends and economic conditions that might affect the business.
  • Competitive Advantage: Ensure the business has a unique selling proposition or competitive edge.

Conclusion

Investing in businesses for investment can be incredibly rewarding. However, it requires a thorough understanding of the market, diligent research, and careful selection. By weighing the potential benefits against the risks and conducting due diligence, investors can enhance their ability to make profitable investments. Always consider consulting a financial advisor to tailor your investment strategy to your personal financial goals and risk tolerance.

Invest wisely, and watch your investments flourish!

Frequently
Asked
Questions
  • How many businesses for sale and investment are listed on SMERGERS?
    There are 20152 active and verified businesses for sale and investment listed on SMERGERS as of 01 September 2025.
  • What level of due diligence does SMERGERS conduct on the businesses/member?

    SMERGERS scrutinizes all profiles and only features a select group of businesses, investors, advisors that meet a basic requirement. When required, certain members may have submitted some form of proof …read more

  • How active are the business profiles listed on SMERGERS?

    We regularly filter out businesses which are inactive or have already closed a transaction. Typically, if the business is actively looking to sell/raise capital, the status is shown in green.

  • How can I be sure about privacy and confidentiality?

    We understand the level of confidentiality required in strategic transactions and we strive to provide a safe and secure experience for our members. Please review our privacy policy. We …read more

  • How can I contact a business listed on SMERGERS?

    You need to be logged in before you connect with a business. Click here to register and message the business If you are already logged in, please use the contact …read more

  • Should you buy an existing business or start a business from scratch?

    Buying an existing business is generally an easier way to start a business with an immediate head start. It saves valuable time and administrative efforts, considering starting from scratch is …read more

  • How successful has SMERGERS been in helping its users successfully close a deal?

    SMERGERS is a discovery and matchmaking platform with a global reach. It helps in connecting Businesses, Investors, Acquirers, Lenders, M&A Advisors and Boutique Investment Banks across locations, industries and transactions. …read more

  • Show more